Skip to main content
. 2021 Feb 16;12(2):378–392. doi: 10.1002/jcsm.12680

Figure 7.

Figure 7

A standardized tissue inhibitor of metalloproteinases‐1 (TIMP‐1)/liver cachexia (sTLC) score predicts survival of colorectal cancer (CRC) and pancreatic cancer (PC) patients. Survival of CRC (A, n = 70) or PC (B, n = 76) patients separated by the sTLC score (RThTIMP‐1: 300 ng/mL, NCRGGT,female < 40 U/L, NCRGGT,male < 60 U/L, NCRCRP < 0.3 mg/dL, NCRferritin,female 15–150 ng/mL, NCRferritin,male 15–200 ng/mL, NCRalbumin 3.5–5.0 g/dL, NCRtotalprotein 6.0–8.0 g/dL).